Touyz R M, Schiffrin E L
Medical Research Council Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, 110 Pine Avenue West, Montreal, Quebec H2W 1R7, Canada.
J Biol Chem. 1996 Oct 4;271(40):24353-8. doi: 10.1074/jbc.271.40.24353.
Vasoactive peptides mobilize cytosolic free Mg2+ in vascular smooth muscle cells. It is unknown whether angiotensin II and arginine vasopressin, potent vasoconstrictor agents, influence intracellular Mg2+. The effects of angiotensin II and vasopressin on intracellular free Mg2+ concentrations ([Mg2+]i) were therefore investigated in primary cultured unpassaged vascular smooth muscle cells (VSMC) from mesenteric arteries of Wistar Kyoto rats, and in an established cell line of rat thoracic aorta cells (A10 cells). Underlying mechanisms of agonist-stimulated [Mg2+]i changes were assessed in A10 cells by pharmacologically manipulating phospholipase C, protein kinase C, and the Na+/H+ exchanger. In addition, the dependence of [Mg2+]i on intracellular Ca2+ was determined. [Mg2+]i was measured in single cells by fluorescent digital imaging using mag-fura-2/AM. Basal [Mg2+]i levels in Wistar Kyoto rat and A10 cells were 0.62 +/- 0.02 mmol/liter and 0.58 +/- 0.01 mmol/liter, respectively. Angiotensin II and vasopressin induced a dose-dependent biphasic [Mg2+]i response where [Mg2+]i increased rapidly and transiently to a peak level and then declined to subbasal levels, which were sustained. Preexposure of cells to neomycin, a nonspecific phospholipase C inhibitor, U-73122, a selective phospholipase C inhibitor, calphostin C, a selective protein kinase C inhibitor, and 5-(N, N-hexamethylene)amiloride, a selective Na+/H+ exchange blocker, attenuated angiotensin II- and vasopressin-induced [Mg2+]i responses in a concentration-dependent manner. Removal of extracellular Na+ completely inhibited agonist-elicited [Mg2+]i transients. To determine whether intracellular free Ca2+ concentration ([Ca2+]i) influences agonist-induced [Mg2+]i changes, thapsigargin, a selective sarcoplasmic reticular Ca2+-ATPase inhibitor, was used to deplete intracellular Ca2+ stores. In thapsigargin-pretreated cells, angiotensin II-elicited [Ca2+]i responses were significantly attenuated, whereas agonist-induced [Mg2+]i responses were unchanged. These data demonstrate that in primary cultured VSMC and in an established VSMC line, angiotensin II and vasopressin modulate [Mg2+]i through receptor-mediated pathways, which are [Ca2+]i-independent but which involve phospholipase C, protein kinase C, and the Na+/H+ exchanger. These pathways are linked to a Na+-dependent Mg2+ transporter, which facilitates transmembrane Mg2+ transport.
血管活性肽可动员血管平滑肌细胞中的胞质游离镁离子。目前尚不清楚血管紧张素II和精氨酸加压素这两种强效血管收缩剂是否会影响细胞内镁离子。因此,本研究在来自Wistar Kyoto大鼠肠系膜动脉的原代培养未传代血管平滑肌细胞(VSMC)以及已建立的大鼠胸主动脉细胞系(A10细胞)中,研究了血管紧张素II和加压素对细胞内游离镁离子浓度([Mg2+]i)的影响。通过药理学方法调控磷脂酶C、蛋白激酶C和Na+/H+交换体,评估了激动剂刺激引起的[Mg2+]i变化的潜在机制。此外,还测定了[Mg2+]i对细胞内钙离子的依赖性。使用mag-fura-2/AM通过荧光数字成像在单细胞中测量[Mg2+]i。Wistar Kyoto大鼠和A10细胞中的基础[Mg2+]i水平分别为0.62±0.02 mmol/升和0.58±0.01 mmol/升。血管紧张素II和加压素诱导了剂量依赖性的双相[Mg2+]i反应,即[Mg2+]i迅速短暂升高至峰值水平,然后降至基础水平以下并持续维持。预先将细胞暴露于新霉素(一种非特异性磷脂酶C抑制剂)、U-73122(一种选择性磷脂酶C抑制剂)、钙泊三醇(一种选择性蛋白激酶C抑制剂)和5-(N,N-六亚甲基)氨氯吡咪(一种选择性Na+/H+交换阻滞剂),可浓度依赖性地减弱血管紧张素II和加压素诱导的[Mg2+]i反应。去除细胞外钠离子可完全抑制激动剂引发的[Mg2+]i瞬变。为了确定细胞内游离钙离子浓度([Ca2+]i)是否影响激动剂诱导的[Mg2+]i变化,使用毒胡萝卜素(一种选择性肌浆网Ca2+-ATP酶抑制剂)耗尽细胞内钙离子储存。在毒胡萝卜素预处理的细胞中,血管紧张素II引发的[Ca2+]i反应显著减弱,而激动剂诱导的[Mg2+]i反应未改变。这些数据表明,在原代培养的VSMC和已建立的VSMC系中,血管紧张素II和加压素通过受体介导的途径调节[Mg2+]i,这些途径不依赖于[Ca2+]i,但涉及磷脂酶C、蛋白激酶C和Na+/H+交换体。这些途径与一种Na+依赖性镁离子转运体相关联,该转运体促进跨膜镁离子转运。